Skip to content

Expression of ApoE, KLK11 and CHI3L1 in serum and tissues of patients with thyroid papillary carcinoma and their clinical significance

Expression of ApoE, KLK11 and CHI3L1 in serum and tissues of patients with thyroid papillary carcinoma and their clinical significance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040341
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-11-27
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary thyroid carcinoma

Interventions

Case series:Nil

Sponsors

The 94th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
28 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1. Preoperative neck color doppler ultrasonography showed thyroid nodules and surgical indications in all patients; 2. The patient's case data were basically complete (including gender, age, tumor diameter, TNM staging lymph node metastasis, tissue differentiation, extracellular invasion and distant metastasis, etc.); 3. No preoperative chemoradiotherapy or any other anti-tumor therapy;4. Patients and their family members know and agree with the researcher; 5. Postoperative pathology further confirmed PTC.

Exclusion criteria

Exclusion criteria: 1. Previous history of tumor or concurrent malignant tumor; 2. History of radiotherapy and chemotherapy for other malignant tumors complicated with autoimmune diseases; 3. Combined with serious cardiopulmonary diseases and other surgical contraindications; 4. Postoperative pathological diagnosis was non-PTC; 5. Patients lost to follow-up after surgery.

Design outcomes

Primary

MeasureTime frame
Immunohistochemical results;Results of enzyme-linked immunosorbent assay (ELISA);

Countries

China

Contacts

Public ContactHong-bin Liu

The 94th Hospital of the Chinese People's Liberation Army Joint Logistic Support Force

liuhongbin999@163.com+86 0931-8994364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026